BC
IMNM icon

BIT Capital’s Immunome IMNM Stock Holding History

BIT Capital’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,927
Closed -$69.4K – 126
2025
Q3 		$69.4K Buy
+5,927
New +$59K ﹤0.01% 94

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BIT Capital's IMNM Position: Q4 2025 in Review

BIT Capital sold out of Immunome (IMNM) in Q4 2025, closing a stake of 5,927 shares — an estimated $69.4K sold.

BIT Capital first reported a position in IMNM in Q3 2025 and held it in 1 quarter. The position peaked at $69.4K in Q3 2025. 182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

  • BIT Capital reported no remaining Immunome position as of Q4 2025 after selling out during the quarter.
  • BIT Capital sold 5,927 Immunome shares in Q4 2025, an estimated $69.4K.
  • BIT Capital first reported a position in Immunome in Q3 2025 and held it in 1 quarter.
  • BIT Capital's Immunome position peaked at $69.4K in Q3 2025.
  • 182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on BIT Capital's 13F filing for Q4 2025, filed 11 Feb 2026.